Extension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 Study

NCT03563053 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

104

Enrollment

INDUSTRY

Sponsor class

Stopped terminated by sponsor

Conditions

Ataxia Telangiectasia
Genetic Syndrome

Interventions

COMBINATION_PRODUCT: EryDex System

Sponsor

Quince Therapeutics S.p.A.